monoclonal antibody targeting PCSK9
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for monoclonal antibody targeting PCSK9, covering 2015-10-05 to 2015-10-05. Get the full timeline:
Most recent: Clinical Trial Update: Monoclonal Antibody Against PCSK9 to Reduce Elevated Low-density Lipoprotein Cholesterol (LDL-C) in Adults Currently Not Receiving Drug Therapy for Easing Lipid Levels [Phase 2]